{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:49:31Z","timestamp":1782373771439,"version":"3.54.5"},"reference-count":85,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,19]],"date-time":"2023-08-19T00:00:00Z","timestamp":1692403200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018927","name":"Southwest Minzu University","doi-asserted-by":"publisher","award":["RQD2022033"],"award-info":[{"award-number":["RQD2022033"]}],"id":[{"id":"10.13039\/501100018927","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019014","name":"Chengdu Municipal Science and Technology Program","doi-asserted-by":"publisher","award":["2022YF05-01626-SN"],"award-info":[{"award-number":["2022YF05-01626-SN"]}],"id":[{"id":"10.13039\/501100019014","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204304"],"award-info":[{"award-number":["82204304"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004829","name":"Science and Technology Department of Sichuan Province","doi-asserted-by":"publisher","award":["2022NSFSC0630"],"award-info":[{"award-number":["2022NSFSC0630"]}],"id":[{"id":"10.13039\/501100004829","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012226","name":"Fundamental Research Funds for the Central Universities","doi-asserted-by":"publisher","award":["ZYN2022057"],"award-info":[{"award-number":["ZYN2022057"]}],"id":[{"id":"10.13039\/501100012226","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018542","name":"Natural Science Foundation of Sichuan Province","doi-asserted-by":"publisher","award":["2023NSFSC1678"],"award-info":[{"award-number":["2023NSFSC1678"]}],"id":[{"id":"10.13039\/501100018542","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine & Pharmacotherapy"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/j.biopha.2023.115353","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T05:46:23Z","timestamp":1692596783000},"page":"115353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"special_numbering":"C","title":["Sialylation: An alternative to designing long-acting and targeted drug delivery system"],"prefix":"10.1016","volume":"166","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-0330-1389","authenticated-orcid":false,"given":"Qixiong","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shanshan","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rongsheng","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxuan","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"9","key":"10.1016\/j.biopha.2023.115353_bib1","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.7150\/thno.14858","article-title":"The smart drug delivery system and its clinical potential","volume":"6","author":"Liu","year":"2016","journal-title":"Theranostics"},{"key":"10.1016\/j.biopha.2023.115353_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113957","article-title":"Polymeric long-acting drug delivery systems (LADDS) for treatment of chronic diseases: inserts, patches, wafers, and implants","volume":"177","author":"Abdelkader","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib3","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2174\/1567201818666210609161301","article-title":"Targeted drug delivery: trends and perspectives","volume":"18","author":"Ashique","year":"2021","journal-title":"Curr. Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115353_bib4","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.cis.2018.11.004","article-title":"Basic principles of drug delivery systems - the case of paclitaxel","volume":"263","author":"Ezrahi","year":"2019","journal-title":"Adv. Colloid Interface Sci."},{"issue":"Pt A","key":"10.1016\/j.biopha.2023.115353_bib5","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.addr.2015.09.012","article-title":"PEGylation as a strategy for improving nanoparticle-based drug and gene delivery","volume":"99","author":"Suk","year":"2016","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115353_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.113851","article-title":"Liposome composition in drug delivery design, synthesis, characterization, and clinical application","volume":"176","author":"Large","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"7","key":"10.1016\/j.biopha.2023.115353_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15071881","article-title":"Research progress of neutrophil-mediated drug delivery strategies for inflammation-related disease","volume":"15","author":"Zhao","year":"2023","journal-title":"Pharmaceutics"},{"issue":"6","key":"10.1016\/j.biopha.2023.115353_bib8","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1016\/j.apsb.2023.03.004","article-title":"Immune cell membrane-based biomimetic nanomedicine for treating cancer metastasis","volume":"13","author":"Zhu","year":"2023","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2023.115353_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114895","article-title":"Stealth and pseudo-stealth nanocarriers","volume":"198","author":"Wen","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115353_bib10","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jconrel.2022.09.002","article-title":"Stealth nanoparticles in oncology: facing the PEG dilemma","volume":"351","author":"Zalba","year":"2022","journal-title":"J. Control Release"},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib11","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41392-022-00947-7","article-title":"Antibody drug conjugate: the \"biological missile\" for targeted cancer therapy","volume":"7","author":"Fu","year":"2022","journal-title":"Signal Transduct. Target Ther."},{"issue":"19","key":"10.1016\/j.biopha.2023.115353_bib12","doi-asserted-by":"crossref","DOI":"10.3390\/molecules26195905","article-title":"Controlled drug delivery systems: current status and future directions","volume":"26","author":"Adepu","year":"2021","journal-title":"Molecules"},{"issue":"2","key":"10.1016\/j.biopha.2023.115353_bib13","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1152\/physrev.00033.2013","article-title":"Sialic acids in the brain: gangliosides and polysialic acid in nervous system development, stability, disease, and regeneration","volume":"94","author":"Schnaar","year":"2014","journal-title":"Physiol. Rev."},{"issue":"7\u20138","key":"10.1016\/j.biopha.2023.115353_bib14","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.drudis.2007.02.010","article-title":"Sialic acids: carbohydrate moieties that influence the biological and physical properties of biopharmaceutical proteins and living cells","volume":"12","author":"Byrne","year":"2007","journal-title":"Drug Discov. Today"},{"issue":"12","key":"10.1016\/j.biopha.2023.115353_bib15","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.1158\/2326-6066.CIR-22-0366","article-title":"Targeting the siglec-sialic acid immune axis in cancer: current and future approaches","volume":"10","author":"Laubli","year":"2022","journal-title":"Cancer Immunol. Res."},{"key":"10.1016\/j.biopha.2023.115353_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114724","article-title":"Recent advances in long-acting drug delivery systems for anticancer drug","volume":"194","author":"Pacheco","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115353_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2023.114860","article-title":"Prodrug approaches for the development of a long-acting drug delivery systems","author":"Chien","year":"2023","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"3","key":"10.1016\/j.biopha.2023.115353_bib18","doi-asserted-by":"crossref","DOI":"10.3390\/pharmaceutics15030935","article-title":"Designing formulation strategies for enhanced stability of therapeutic peptides in aqueous solutions: a review","volume":"15","author":"Nugrahadi","year":"2023","journal-title":"Pharmaceutics"},{"key":"10.1016\/j.biopha.2023.115353_bib19","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.jconrel.2022.09.031","article-title":"Polyethylene glycol (PEG): the nature, immunogenicity, and role in the hypersensitivity of PEGylated products","volume":"351","author":"Ibrahim","year":"2022","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115353_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.addr.2021.114079","article-title":"To PEGylate or not to PEGylate: immunological properties of nanomedicine's most popular component, polyethylene glycol and its alternatives","volume":"180","author":"Shi","year":"2022","journal-title":"Adv. Drug Deliv. Rev."},{"issue":"sup1","key":"10.1016\/j.biopha.2023.115353_bib21","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1080\/10717544.2017.1388451","article-title":"Cleavable PEGylation: a strategy for overcoming the \"PEG dilemma\" in efficient drug delivery","volume":"24","author":"Fang","year":"2017","journal-title":"Drug Deliv."},{"issue":"4","key":"10.1016\/j.biopha.2023.115353_bib22","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.apsb.2021.02.022","article-title":"Innate and adaptive immune responses toward nanomedicines","volume":"11","author":"Viana","year":"2021","journal-title":"Acta Pharm. Sin. B"},{"key":"10.1016\/j.biopha.2023.115353_bib23","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1016\/j.addr.2020.07.024","article-title":"Anti-PEG antibodies: properties, formation, testing and role in adverse immune reactions to PEGylated nano-biopharmaceuticals","volume":"154\u2013155","author":"Kozma","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.biopha.2023.115353_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijbiomac.2023.123151","article-title":"A brief review of polysialic acid-based drug delivery systems","volume":"230","author":"Zhang","year":"2023","journal-title":"Int. J. Biol. Macromol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115353_bib25","first-page":"183","article-title":"Cationic polymers for gene delivery: designs for overcoming barriers to systemic administration","volume":"3","author":"Hwang","year":"2001","journal-title":"Curr. Opin. Mol. Ther."},{"issue":"9","key":"10.1016\/j.biopha.2023.115353_bib26","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20092350","article-title":"Self-assembled benznidazole-loaded cationic nanoparticles containing cholesterol\/sialic acid: physicochemical properties, in vitro drug release and in vitro anticancer efficacy","volume":"20","author":"Dos Santos-Silva","year":"2019","journal-title":"Int. J. Mol. Sci."},{"issue":"5","key":"10.1016\/j.biopha.2023.115353_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/cells10051260","article-title":"Siglec ligands","volume":"10","author":"Gonzalez-Gil","year":"2021","journal-title":"Cells"},{"issue":"20","key":"10.1016\/j.biopha.2023.115353_bib28","doi-asserted-by":"crossref","first-page":"4976","DOI":"10.1016\/j.bmcl.2016.09.004","article-title":"Reduced immune response to polymeric micelles coating sialic acids","volume":"26","author":"Ohmae","year":"2016","journal-title":"Bioorg. Med. Chem. Lett."},{"issue":"4","key":"10.1016\/j.biopha.2023.115353_bib29","doi-asserted-by":"crossref","first-page":"962","DOI":"10.7150\/thno.19061","article-title":"Development of sialic acid-coated nanoparticles for targeting cancer and efficient evasion of the immune system","volume":"7","author":"Kim","year":"2017","journal-title":"Theranostics"},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib30","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/S0167-4838(97)00056-3","article-title":"Polysialylated asparaginase: preparation, activity and pharmacokinetics","volume":"1341","author":"Fernandes","year":"1997","journal-title":"Biochim. Biophys. Acta"},{"key":"10.1016\/j.biopha.2023.115353_bib31","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.3389\/fimmu.2019.01068","article-title":"L-selectin: a major regulator of leukocyte adhesion, migration and signaling","volume":"10","author":"Ivetic","year":"2019","journal-title":"Front. Immunol."},{"issue":"2","key":"10.1016\/j.biopha.2023.115353_bib32","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.ijpharm.2017.10.027","article-title":"E-selectin targeted immunoliposomes for rapamycin delivery to activated endothelial cells","volume":"548","author":"Gholizadeh","year":"2018","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib33","article-title":"Selectin ligands Sialyl-Lewis a and Sialyl-Lewis x in gastrointestinal cancers","volume":"6","author":"Trinchera","year":"2017","journal-title":"Biol. (Basel)"},{"issue":"20","key":"10.1016\/j.biopha.2023.115353_bib34","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1182\/blood-2018-11-844530","article-title":"Neutrophils and NETs in modulating acute and chronic inflammation","volume":"133","author":"Castanheira","year":"2019","journal-title":"Blood"},{"key":"10.1016\/j.biopha.2023.115353_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2022.866747","article-title":"Targeting neutrophils for promoting the resolution of inflammation","volume":"13","author":"Filep","year":"2022","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115353_bib36","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.biocel.2012.12.023","article-title":"Signals regulating L-selectin-dependent leucocyte adhesion and transmigration","volume":"45","author":"Ivetic","year":"2013","journal-title":"Int. J. Biochem. Cell Biol."},{"issue":"5","key":"10.1016\/j.biopha.2023.115353_bib37","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1016\/S0959-440X(02)00365-2","article-title":"Regulatory roles of carbohydrate ligands for selectins in the homing of lymphocytes","volume":"12","author":"Kannagi","year":"2002","journal-title":"Curr. Opin. Struct. Biol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115353_bib38","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/j.autrev.2018.06.006","article-title":"Neutrophils: novel key players in rheumatoid arthritis. Current and future therapeutic targets","volume":"17","author":"Cecchi","year":"2018","journal-title":"Autoimmun. Rev."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/nrrheum.2014.80","article-title":"The multifactorial role of neutrophils in rheumatoid arthritis","volume":"10","author":"Wright","year":"2014","journal-title":"Nat. Rev. Rheuma"},{"issue":"7","key":"10.1016\/j.biopha.2023.115353_bib40","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1007\/s11095-019-2609-4","article-title":"Neutrophil-mediated delivery of dexamethasone palmitate-loaded liposomes decorated with a sialic acid conjugate for rheumatoid arthritis treatment","volume":"36","author":"Hu","year":"2019","journal-title":"Pharm. Res."},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib41","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1208\/s12249-020-01870-2","article-title":"Sialic acid conjugate-modified liposomal dexamethasone palmitate targeting neutrophils for rheumatoid arthritis therapy: influence of particle size","volume":"22","author":"Wang","year":"2021","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2023.115353_bib42","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.3389\/fimmu.2020.01749","article-title":"The emerging role of neutrophil extracellular traps (NETs) in tumor progression and metastasis","volume":"11","author":"Masucci","year":"2020","journal-title":"Front. Immunol."},{"issue":"3","key":"10.1016\/j.biopha.2023.115353_bib43","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/s41577-021-00571-6","article-title":"Neutrophils in cancer: heterogeneous and multifaceted","volume":"22","author":"Hedrick","year":"2022","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib44","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1016\/j.it.2012.05.007","article-title":"The pros and cons of chemokines in tumor immunology","volume":"33","author":"Viola","year":"2012","journal-title":"Trends Immunol."},{"issue":"18","key":"10.1016\/j.biopha.2023.115353_bib45","doi-asserted-by":"crossref","first-page":"3788","DOI":"10.1158\/0008-5472.CAN-15-0054","article-title":"IL17 promotes mammary tumor progression by changing the behavior of tumor cells and eliciting tumorigenic neutrophils recruitment","volume":"75","author":"Benevides","year":"2015","journal-title":"Cancer Res."},{"issue":"7556","key":"10.1016\/j.biopha.2023.115353_bib46","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nature14282","article-title":"IL-17-producing gammadelta T cells and neutrophils conspire to promote breast cancer metastasis","volume":"522","author":"Coffelt","year":"2015","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.biopha.2023.115353_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbcan.2022.188762","article-title":"Tumor-associated neutrophils and neutrophil-targeted cancer therapies","volume":"1877","author":"Que","year":"2022","journal-title":"Biochim. Biophys. Acta Rev. Cancer"},{"issue":"7","key":"10.1016\/j.biopha.2023.115353_bib48","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nnano.2017.54","article-title":"Neutrophil-mediated anticancer drug delivery for suppression of postoperative malignant glioma recurrence","volume":"12","author":"Xue","year":"2017","journal-title":"Nat. Nanotechnol."},{"issue":"9","key":"10.1016\/j.biopha.2023.115353_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/adhm.202002071","article-title":"Neutrophil and nanoparticles delivery to tumor: is it going to carry that weight?","volume":"10","author":"Vishnevskiy","year":"2021","journal-title":"Adv. Health Mater."},{"issue":"4","key":"10.1016\/j.biopha.2023.115353_bib50","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.immuni.2011.09.004","article-title":"Beginnings of a good apoptotic meal: the find-me and eat-me signaling pathways","volume":"35","author":"Ravichandran","year":"2011","journal-title":"Immunity"},{"issue":"8","key":"10.1016\/j.biopha.2023.115353_bib51","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.it.2010.05.006","article-title":"Neutrophil kinetics in health and disease","volume":"31","author":"Summers","year":"2010","journal-title":"Trends Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib52","doi-asserted-by":"crossref","DOI":"10.3390\/cancers12102841","article-title":"Investigating patterns of immune interaction in ovarian cancer: probing the O-glycoproteome by the macrophage galactose-like C-type lectin (MGL)","volume":"12","author":"Napoletano","year":"2020","journal-title":"Cancers (Basel)"},{"issue":"11","key":"10.1016\/j.biopha.2023.115353_bib53","doi-asserted-by":"crossref","first-page":"2120","DOI":"10.1007\/s11095-007-9406-1","article-title":"Targeted sialic acid-doxorubicin prodrugs for intracellular delivery and cancer treatment","volume":"24","author":"Jayant","year":"2007","journal-title":"Pharm. Res."},{"issue":"9","key":"10.1016\/j.biopha.2023.115353_bib54","doi-asserted-by":"crossref","first-page":"4235","DOI":"10.1021\/acs.molpharmaceut.8b00649","article-title":"Sialic-acid-anchored micelles: a hierarchical targeting device for enhanced tumor tissue accumulation and cellular internalization","volume":"15","author":"Zhu","year":"2018","journal-title":"Mol. Pharm."},{"issue":"38","key":"10.1016\/j.biopha.2023.115353_bib55","doi-asserted-by":"crossref","first-page":"31903","DOI":"10.1021\/acsami.8b09498","article-title":"Sialic acid-functionalized pH-triggered micelles for enhanced tumor tissue accumulation and active cellular internalization of orthotopic hepatocarcinoma","volume":"10","author":"Xu","year":"2018","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5","key":"10.1016\/j.biopha.2023.115353_bib56","first-page":"1423","article-title":"Sialic acid-engineered mesoporous polydopamine nanoparticles loaded with SPIO and Fe(3+) as a novel theranostic agent for T1\/T2 dual-mode MRI-guided combined chemo-photothermal treatment of hepatic cancer","volume":"6","author":"Shu","year":"2021","journal-title":"Bioact. Mater."},{"issue":"8","key":"10.1016\/j.biopha.2023.115353_bib57","doi-asserted-by":"crossref","first-page":"3694","DOI":"10.1021\/acs.molpharmaceut.9b00616","article-title":"Highly integrated nanoplatform based on an E-selectin-targeting strategy for metastatic breast cancer treatment","volume":"16","author":"Xu","year":"2019","journal-title":"Mol. Pharm."},{"key":"10.1016\/j.biopha.2023.115353_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2022.121900","article-title":"Inflammation-targeted sialic acid-dexamethasone conjugates for reducing the side effects of glucocorticoids","volume":"622","author":"Liu","year":"2022","journal-title":"Int. J. Pharm."},{"issue":"6","key":"10.1016\/j.biopha.2023.115353_bib59","doi-asserted-by":"crossref","first-page":"2923","DOI":"10.1039\/C7NR08430G","article-title":"Endogenous sialic acid-engineered micelles: a multifunctional platform for on-demand methotrexate delivery and bone repair of rheumatoid arthritis","volume":"10","author":"Xu","year":"2018","journal-title":"Nanoscale"},{"issue":"4","key":"10.1016\/j.biopha.2023.115353_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1049\/iet-nbt.2019.0363","article-title":"Sialic acid-conjugated PLGA nanoparticles enhance the protective effect of lycopene in chemotherapeutic drug-induced kidney injury","volume":"14","author":"Xiao","year":"2020","journal-title":"IET Nanobiotechnol."},{"issue":"6","key":"10.1016\/j.biopha.2023.115353_bib61","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1002\/art.1780380606","article-title":"Expression of E-selectin messenger RNA and protein in rheumatoid arthritis","volume":"38","author":"Kriegsmann","year":"1995","journal-title":"Arthritis Rheum."},{"issue":"2","key":"10.1016\/j.biopha.2023.115353_bib62","doi-asserted-by":"crossref","first-page":"87","DOI":"10.2165\/00002512-199609020-00003","article-title":"Cell adhesion molecules in rheumatoid arthritis","volume":"9","author":"Veale","year":"1996","journal-title":"Drugs Aging"},{"issue":"8","key":"10.1016\/j.biopha.2023.115353_bib63","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1002\/art.1780390815","article-title":"Use of a radiolabeled monoclonal antibody against E-selectin for imaging of endothelial activation in rheumatoid arthritis","volume":"39","author":"Chapman","year":"1996","journal-title":"Arthritis Rheum."},{"issue":"6","key":"10.1016\/j.biopha.2023.115353_bib64","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.tibs.2016.03.007","article-title":"Sialic acid mimetics to target the sialic acid-siglec axis","volume":"41","author":"Bull","year":"2016","journal-title":"Trends Biochem. Sci."},{"key":"10.1016\/j.biopha.2023.115353_bib65","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.790317","article-title":"Siglec signaling in the tumor microenvironment","volume":"12","author":"van Houtum","year":"2021","journal-title":"Front. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib66","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nri3737","article-title":"Siglec-mediated regulation of immune cell function in disease","volume":"14","author":"Macauley","year":"2014","journal-title":"Nat. Rev. Immunol."},{"issue":"10","key":"10.1016\/j.biopha.2023.115353_bib67","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.tips.2015.06.008","article-title":"Therapeutic targeting of siglecs using antibody- and glycan-based approaches","volume":"36","author":"Angata","year":"2015","journal-title":"Trends Pharm. Sci."},{"key":"10.1016\/j.biopha.2023.115353_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.583084","article-title":"Tumor-associated macrophages in tumor immunity","volume":"11","author":"Pan","year":"2020","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2023.115353_bib69","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.3389\/fimmu.2020.01731","article-title":"Redefining tumor-associated macrophage subpopulations and functions in the tumor microenvironment","volume":"11","author":"Wu","year":"2020","journal-title":"Front. Immunol."},{"issue":"11","key":"10.1016\/j.biopha.2023.115353_bib70","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S1471-4906(02)02302-5","article-title":"Macrophage polarization: tumor-associated macrophages as a paradigm for polarized M2 mononuclear phagocytes","volume":"23","author":"Mantovani","year":"2002","journal-title":"Trends Immunol."},{"issue":"19","key":"10.1016\/j.biopha.2023.115353_bib71","doi-asserted-by":"crossref","first-page":"5216","DOI":"10.1016\/j.biomaterials.2014.03.022","article-title":"The anticancer efficacy of pixantrone-loaded liposomes decorated with sialic acid-octadecylamine conjugate","volume":"35","author":"She","year":"2014","journal-title":"Biomaterials"},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib72","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.ijpharm.2017.03.034","article-title":"Targeted delivery of epirubicin to tumor-associated macrophages by sialic acid-cholesterol conjugate modified liposomes with improved antitumor activity","volume":"523","author":"Zhou","year":"2017","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115353_bib73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1016\/j.ijpharm.2019.01.005","article-title":"Exhausting tumor associated macrophages with sialic acid-polyethyleneimine-cholesterol modified liposomal doxorubicin for enhancing sarcoma chemotherapy","volume":"558","author":"Zheng","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115353_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2019.118706","article-title":"Terminating the renewal of tumor-associated macrophages: a sialic acid-based targeted delivery strategy for cancer immunotherapy","volume":"571","author":"Ding","year":"2019","journal-title":"Int. J. Pharm."},{"key":"10.1016\/j.biopha.2023.115353_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2020.119929","article-title":"Targeted delivery of zoledronic acid through the sialic acid - Siglec axis for killing and reversal of M2 phenotypic tumor-associated macrophages - a promising cancer immunotherapy","volume":"590","author":"Tang","year":"2020","journal-title":"Int. J. Pharm."},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib76","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1080\/10717544.2021.1971797","article-title":"Combination immunotherapy of chlorogenic acid liposomes modified with sialic acid and PD-1 blockers effectively enhances the anti-tumor immune response and therapeutic effects","volume":"28","author":"Li","year":"2021","journal-title":"Drug Deliv."},{"key":"10.1016\/j.biopha.2023.115353_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijpharm.2021.120552","article-title":"Sequential administration of sialic acid-modified liposomes as carriers for epirubicin and zoledronate elicit stronger antitumor effects with reduced toxicity","volume":"602","author":"Sui","year":"2021","journal-title":"Int. J. Pharm."},{"issue":"8","key":"10.1016\/j.biopha.2023.115353_bib78","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1208\/s12249-022-02432-4","article-title":"An application of tumor-associated macrophages as immunotherapy targets: sialic acid-modified EPI-loaded liposomes inhibit breast cancer metastasis","volume":"23","author":"Meng","year":"2022","journal-title":"AAPS PharmSciTech"},{"key":"10.1016\/j.biopha.2023.115353_bib79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.actbio.2019.05.030","article-title":"Targeted delivery of ibrutinib to tumor-associated macrophages by sialic acid-stearic acid conjugate modified nanocomplexes for cancer immunotherapy","volume":"92","author":"Qiu","year":"2019","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2023.115353_bib80","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1016\/j.actbio.2021.07.063","article-title":"Sialic acid conjugate-modified liposomes enable tumor homing of epirubicin via neutrophil\/monocyte infiltration for tumor therapy","volume":"134","author":"Ding","year":"2021","journal-title":"Acta Biomater."},{"key":"10.1016\/j.biopha.2023.115353_bib81","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.actbio.2022.06.033","article-title":"Polysialylated nanoinducer for precisely enhancing apoptosis and anti-tumor immune response in B-cell lymphoma","volume":"149","author":"Zhang","year":"2022","journal-title":"Acta Biomater."},{"issue":"36","key":"10.1016\/j.biopha.2023.115353_bib82","doi-asserted-by":"crossref","first-page":"12450","DOI":"10.1021\/jacs.7b03208","article-title":"CD22 ligands on a natural N-glycan scaffold efficiently deliver toxins to B-lymphoma cells","volume":"139","author":"Peng","year":"2017","journal-title":"J. Am. Chem. Soc."},{"key":"10.1016\/j.biopha.2023.115353_bib83","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.msec.2019.04.065","article-title":"Targeting human brain cancer stem cells by curcumin-loaded nanoparticles grafted with anti-aldehyde dehydrogenase and sialic acid: colocalization of ALDH and CD44","volume":"102","author":"Kuo","year":"2019","journal-title":"Mater. Sci. Eng. C. Mater. Biol. Appl."},{"issue":"1","key":"10.1016\/j.biopha.2023.115353_bib84","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jconrel.2010.03.008","article-title":"Sialic acid and glycopeptides conjugated PLGA nanoparticles for central nervous system targeting: in vivo pharmacological evidence and biodistribution","volume":"145","author":"Tosi","year":"2010","journal-title":"J. Control Release"},{"key":"10.1016\/j.biopha.2023.115353_bib85","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cbpa.2021.01.001","article-title":"Siglec and anti-Siglec therapies","volume":"62","author":"Murugesan","year":"2021","journal-title":"Curr. Opin. Chem. Biol."}],"container-title":["Biomedicine & Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011447?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0753332223011447?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T07:28:35Z","timestamp":1782372515000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0753332223011447"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023,10]]},"references-count":85,"alternative-id":["S0753332223011447"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115353","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sialylation: An alternative to designing long-acting and targeted drug delivery system","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2023.115353","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Authors. Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"115353"}}